Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 7Gynecologic 2Breast 2Thoracic 1Head & Neck 1Dermatologic 1

Conditions

Triple Negative Breast Neoplasms 1Carcinoma, Ductal, Breast 1

Interventions

Cyclophosphamide 171Docetaxel 163Paclitaxel 160Trastuzumab 151Capecitabine 130Tamoxifen 119Letrozole 105Epirubicin 93Doxorubicin 83Anastrozole 83exemestane 77Fulvestrant 75Carboplatin 64Fluorouracil 63Radiotherapy 61pertuzumab 59Gemcitabine 55Vinorelbine 43Goserelin 39eribulin 36130-nm albumin-bound paclitaxel 36palbociclib 32Bevacizumab 32ribociclib 30Zoledronic Acid 29Lapatinib 29Methotrexate 28Drug Therapy 28Chemotherapy, Adjuvant 28Ado-Trastuzumab Emtansine 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × TP protocol × Breast × Clear all
NCT03201861 2025-05-16

Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women

RenJi Hospital

Phase 3 Recruiting
762 enrolled
Breast

Carcinoma, Ductal, Breast

NCT01216111 2020-05-19

Adjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN)

Fudan University

Phase 3 Completed
647 enrolled
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡